Changes of plasma fibrinogen level among acute ischemic stroke subtypes according to TOAST criteria and effects of Songling Xuemaikang

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 10, 2010, Pages 1339-1341

  Yang, Degang ^a   Lu, Nianfang ^a   Liu, Xiaojie ^a   Liu, Gang ^a   Xu, Yao ^a   Huang, Jinzhong ^a   Chen, Yingzhu ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Fibrinogen; Songling Xuemaikang; TOAST criteria

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CHINESE DRUG; FIBRINOGEN; SHUXUETONG; SONGLING XUEMAIKANG; UNCLASSIFIED DRUG;

ACUTE DISEASE; ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ASPIRIN; BRAIN ISCHEMIA; DRUGS, CHINESE HERBAL; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

EID: 77955638576     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20101026     Document Type: Article

References (7)

1. James F Meschia, Kevin M Barrett. Interobserver agreement in the TOAST classification of stroke based on retrospective medical record review[J]. J Stroke Cerebrovasc Dis, 2006,15(6):266.
2. Jood K, Danielson J, Ladenvall C, et al. Fibrinogen gene variation and ischemic stroke[J]. Thromb Haemost, 2008,6(6):897.
3. Vibo R, K? rv J, Roose M, et al. Acute phase proteins and oxidised low - density lipoprotein in association with ischemic stroke subtype, severity and outcome[J]. 2007,41(3):282.
4. Del Zoppo G J, Levy D E, Wasiewski W W, et al. Hyperfibrino-genemia and functional outcome from acute ischemic stroke[J]. Stroke, 2009,40(5):1687.
5. Iskra T, Turaj W, S? owik A, et al. Hemostatic markers of endothelial injury in ischemic stroke caused by large or small vessel disease[J]. Pol Merkur Lekarski, 2006,21(125):429.